{"id":"NCT02128932","sponsor":"Novo Nordisk A/S","briefTitle":"Efficacy and Safety of Semaglutide Once Weekly Versus Insulin Glargine Once Daily as add-on to Metformin With or Without Sulphonylurea in Insulin-naïve Subjects With Type 2 Diabetes","officialTitle":"Efficacy and Safety of Semaglutide Once Weekly Versus Insulin Glargine Once Daily as Add on to Metformin With or Without Sulphonylurea in Insulin-naïve Subjects With Type 2 Diabetes","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2014-08-04","primaryCompletion":"2015-09-03","completion":"2015-09-03","firstPosted":"2014-05-01","resultsPosted":"2018-03-08","lastUpdate":"2019-06-13"},"enrollment":1089,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Diabetes","Diabetes Mellitus, Type 2"],"interventions":[{"type":"DRUG","name":"semaglutide","otherNames":[]},{"type":"DRUG","name":"insulin glargine","otherNames":[]}],"arms":[{"label":"Semaglutide 0.5 mg/week","type":"EXPERIMENTAL"},{"label":"Semaglutide 1.0 mg/week","type":"EXPERIMENTAL"},{"label":"Insulin glargine","type":"ACTIVE_COMPARATOR"}],"summary":"This trial is conducted in Africa, North and South America, Asia and Europe. The purpose of the trial is to compare the effect of once-weekly dosing of two dose levels of semaglutide versus insulin glargine once-daily on glycaemic control after 30 weeks of treatment in insulin-naïve subjects with type 2 diabetes.","primaryOutcome":{"measure":"Change in HbA1c From Baseline","timeFrame":"Week 0, week 30","effectByArm":[{"arm":"Semaglutide 0.5mg/Week","deltaMin":-1.21,"sd":0.05},{"arm":"Semaglutide 1.0 mg/Week","deltaMin":-1.64,"sd":0.05},{"arm":"Insulin Glargine","deltaMin":-0.83,"sd":0.05}],"pValues":[{"comp":"OG001 vs OG002","p":"<0.0001"},{"comp":"OG000 vs OG002","p":"<0.0001"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":3,"exclusionCount":12},"locations":{"siteCount":231,"countries":["United States","Argentina","Croatia","France","Germany","India","Mexico","Netherlands","North Macedonia","Puerto Rico","Romania","Slovakia","Slovenia","South Africa","United Kingdom"]},"refs":{"pmids":["30865526","28344112","28526920","29687620","29766634","29862621","30615985","32998732","32193837","31903692","31769496","31215727"],"seeAlso":["http://novonordisk-trials.com"]},"adverseEventsSummary":{"seriousAny":{"events":22,"n":362},"commonTop":["Nausea","Diarrhoea","Nasopharyngitis","Lipase increased","Vomiting"]}}